A role for Cdkl1 in the development of gastric cancer

References

• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
   PubMed Web of Science ®Google Scholar
• Begnami MD, Fregnani JH, Nonogaki S, Soares FA. Evaluation of cell cycle protein expression in gastric cancer: Cyclin B1 expression and its prognostic implication. Hum Pathol 2010;41:1120–7.
   PubMed Web of Science ®Google Scholar
• Kim DH. Prognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancer. Yonsei Med J 2007;48:694–700.
   PubMed Web of Science ®Google Scholar
• Camp ER, Li J, Minnich DJ, Brank A, Moldawer LL, MacKay SL, . Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer. J Am Coll Surg 2004;199:249–58.
   PubMed Web of Science ®Google Scholar
• Lee BL, Lee HS, Jung J, Cho SJ, Chung HY, Kim WH, . Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer. Clin Cancer Res 2005;11:2518–25.
   PubMed Web of Science ®Google Scholar
• Park ES, Do IG, Park CK, Kang WK, Noh JH, Sohn TS, . Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection. Clin Cancer Res 2009;15:291–8.
   PubMed Web of Science ®Google Scholar
• de Maat MF, van de Velde CJ, Umetani N, de Heer P, Putter H, van Hoesel AQ, . Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. J Clin Oncol 2007;25:4887–94.
   PubMed Web of Science ®Google Scholar
• Xia L, Yuan YZ, Xu CD, Zhang YP, Qiao MM, Xu JX. Effects of epidermal growth factor on the growth of human gastric cancer cell and the implanted tumor of nude mice. World J Gastroenterol 2002;8:455–8.
   PubMed Web of Science ®Google Scholar
• Moon WS, Tarnawski AS, Chai J, Yang JT, Majumdar AP. Reduced expression of epidermal growth factor receptor related protein in gastric cancer. Gut 2005;54:201–6.
   PubMed Web of Science ®Google Scholar
• Wu WK, Cho CH, Lee CW, Fan D, Wu K, Yu J, . Dysregulation of cellular signaling in gastric cancer. Cancer Lett 2010;295:144–53.
   PubMed Web of Science ®Google Scholar
• Malumbres M, Harlow E, Hunt T, Hunter T, Lahti JM, Manning G, . Cyclin-dependent kinases: A family portrait. Nat Cell Biol 2009;11:1275–6.
   PubMed Web of Science ®Google Scholar
• Meyerson M, Enders GH, Wu CL, Su LK, Gorka C, Nelson C, . A family of human cdc2-related protein kinases. EMBO J 1992;11:2909–17.
   PubMed Web of Science ®Google Scholar
• Taglienti CA, Wysk M, Davis RJ. Molecular cloning of the epidermal growth factor-stimulated protein kinase p56 KKIAMRE. Oncogene 1996;13:2563–74.
   PubMed Web of Science ®Google Scholar
• Yen SH, Kenessey A, Lee SC, Dickson DW. The distribution and biochemical properties of a Cdc2-related kinase, KKIALRE, in normal and Alzheimer brains. J Neurochem 1995;65:2577–84.
   PubMed Web of Science ®Google Scholar
• Pacek M, Prokhorova TA, Walter JC. Cdk1: Unsung hero of S phase? Cell Cycle 2004;3:401–3.
   PubMed Web of Science ®Google Scholar
• Wegiel B, Bjartell A, Ekberg J, Gadaleanu V, Brunhoff C, Persson JL. A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer. Oncogene 2005;24:6385–93.
   Google Scholar
• Zhang S, Yang JH, Guo CK, Cai PC. Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells. Cancer Lett 2007;253:108–14.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–8.
   PubMed Web of Science ®Google Scholar
• Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, . A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003; 33:401–6.
   PubMed Web of Science ®Google Scholar
• Raoul C, Abbas-Terki T, Bensadoun JC, Guillot S, Haase G, Szulc J, . Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 2005;11:423–8.
   PubMed Web of Science ®Google Scholar
• Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, . Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature 2008;451:335–9.
   PubMed Web of Science ®Google Scholar
• Janjigian YY, Shah MA. Molecularly targeted therapies in advanced gastric cancer. Minerva Gastroenterol Dietol 2011; 57:75–88.
   PubMedGoogle Scholar
• Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N. Expression and prognostic role of cyclin- dependent kinase 1 (cdc2) in hepatocellular carcinoma. Oncology 2000;59:68–74.
   PubMed Web of Science ®Google Scholar
• Ito Y, Yoshida H, Matsuzuka F, Matsuura N, Nakamura Y, Nakamine H, . Cdc2 expression in primary thyroid lymphoma: Its relationship with biological aggressiveness and G2 cyclins. Pathol Res Pract 2003;199:533–8.
   PubMed Web of Science ®Google Scholar